AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 NOV 4 - (NewsRx.com & NewsRx.net) -- Researchers in the U.K. have identified specific vitamin D receptor gene polymorphisms that appear to be associated with breast cancer risk.
"The steroid hormone 1,25-dihydroxyvitamin D is thought to protect against breast cancer. The actions of 1,25-dihydroxyvitamin D, are mediated via the vitamin D receptor (VDR), and a number of polymorphisms in the VDR gene have been identified. These result in distinct genotypes, some of which may alter susceptibility to breast cancer.
"We have investigated whether specific VDR gene polymorphisms are associated with breast cancer risk in a United Kingdom Caucasian population," said M. Guy, K.W. Colston, and colleagues. "In a retrospective case-control study, female breast cancer patients (n=398) and control women (n=427) were recruited, and three VDR polymorphisms were determined."
The researchers reported, "The 3' VDR polymorphisms BsmI and variable-length poly(adenylate) sequence were both significantly associated with breast cancer risk; odds ratios (adjusted for age menopausal status and hormone replacement therapy usage) for bb genotype versus BB genotype = 1.92 (95% confidence interval [CI], 1.20-3.10; p
"A 5' VDR gene variant, FokI, was not associated with breast cancer risk when analyzed in isolation (p>0.05). However, FokI did modulate the increased risk associated with the MILL genotype such that possession ...